Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results. (Q53450729)
Jump to navigation
Jump to search
scientific article published in September 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results. |
scientific article published in September 2008 |
Statements
Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results. (English)
Robert J Amato
Jaroslaw Jac
Joan Hernandez-McClain
1 September 2008
6
2
73-78